OPTH Optimi Health Corp. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$5.05

Period return

-1.03 (-16.94%)

Volume

30.2K

2026-08-07O $5.01 H $5.15 L $4.9 C $5.05MA5 $4.97MA20 $4.79

6M · 55 barsYahoo Finance · USD2026-05-20 → 2026-08-07

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

No events to show.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Rating & price-target changes

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ: Princeton, BC, Canada
Fiscal year end: —
Employees: —
IPO date: —

View details →

Optimi Health Corp.

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats